50 Mg Vinorelbine Injection IP

Name: 50 Mg Vinorelbine Injection IP
Brand: NEETCO BIOPHARMA
Price: 4499 INR
Availability: InStock

Price 4499 INR/ Vial

Get a Price/Quote

MOQ : 1000 Vials

50 Mg Vinorelbine Injection IP Specification

Dosage Form
Injection

Salt Composition
Vinorelbine 50 mg

Indication
Treatment of non-small cell lung cancer and advanced breast cancer

Feature
Single-use vial, cytotoxic agent

Ingredients
Vinorelbine tartrate and excipients

Application
Intravenous use

Ph Level
Approximately 3.5

Physical Color/Texture
Clear, colorless to pale yellow liquid

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C. Do not freeze. Keep away from light.

Shelf Life
24 months

Regulatory Status
Prescription only, Schedule H drug

Disposal
Dispose of unused product and waste materials according to local regulations for cytotoxic agents.

Reconstitution
Ready-to-use, no reconstitution needed

Strength
50 mg/5 ml

Administration Route
Intravenous only

Chemotherapeutic Class
Vinca alkaloid cytotoxic agent

Adverse Effects
Neutropenia, anemia, constipation, peripheral neuropathy, nausea, vomiting

Packaging Size
Single vial (5 ml)

Compatibility
Must not be mixed with other drugs in the same syringe or infusion.

Contraindications
Patients with neutrophil count <1500 cells/mm³ or with severe hepatic impairment

Precautions
For hospital use only. Handle with care, use appropriate protective equipment.

About 50 Mg Vinorelbine Injection IP

Unlock the gilt-edged potential of 50 Mg Vinorelbine Injection IP, grandiose in its clinical efficacy for the glorious treatment of non-small cell lung cancer and advanced breast cancer. Highly recommended and ready-to-use, this single-use vial offers a safe intravenous application with precise Vinorelbine tartrate. Utilise offer from leading distributor, exporter, supplier, and trader in India. Ensure optimal administration by handling with care and protective equipment in hospital settings. Dispose according to local cytotoxic regulations. Its glorious shelf life is 24 months. For hospital use only. Prescription & Schedule H drug.

Usage & Application of Vinorelbine Injection IP

Vinorelbine Injection IP, 50 mg/5 ml, is used for hospital-based intravenous chemotherapy, specifically for non-small cell lung cancer and advanced breast cancer. Applied as a ready-to-use solution, its usage type is strictly injection, ensuring swift delivery of cytotoxic effects. Designed as a single-use vial, it must be administered by healthcare professionals with appropriate safety protocols. The injection's gilt-edged formulation provides targeted cancer care as endorsed by oncology experts.

Order Completion & Supply Advantages

We offer Vinorelbine Injection IP with express shipping from India's major FOB ports, facilitating prompt global distribution. Engage our distributor and supplier network to request an asking price or negotiate favorable payment terms, including advance payments and L/C. With a robust supply ability, every order completion is handled efficiently, ensuring swift availability and seamless support for hospitals and clinics seeking this glorious cancer therapy.

FAQ's of 50 Mg Vinorelbine Injection IP:

Q: How should 50 Mg Vinorelbine Injection IP be correctly administered?

A: This injection must be given intravenously by a qualified healthcare professional, strictly within a hospital setting, using appropriate protective equipment to ensure safety.

Q: What are the primary indications for Vinorelbine Injection IP?

A: Vinorelbine Injection IP is indicated for the treatment of non-small cell lung cancer and advanced breast cancer, providing targeted cytotoxic therapy as part of oncology care.

Q: When is Vinorelbine Injection IP contraindicated?

A: The injection should not be used in patients whose neutrophil count is below 1500 cells/mm3 or those suffering from severe hepatic impairment due to risk of adverse effects.

Q: Where can unused Vinorelbine Injection IP and waste materials be disposed of?

A: All unused vials and waste should be disposed of according to local regulations for cytotoxic agents to ensure safe and compliant handling of hazardous materials.

Q: What adverse effects may occur during the process of Vinorelbine administration?

A: Patients may experience neutropenia, anemia, constipation, peripheral neuropathy, nausea, or vomiting during treatment, necessitating close monitoring by medical staff.

Q: How does using a ready-to-use, single-use vial benefit hospital operations?

A: The ready-to-use, single-use vial format streamlines preparation, minimizes contamination risks, and ensures precise dosage delivery for every treatment cycle.

Tell us about your requirement